Newsfeeds - Spark Newswire

4 minute read

Psyched: Atai Launches ‘Salvia Divinorum’ Subsidiary, Mindset, Psilera and Wesana’s Preclinical Trials, Origin Raises $5M

Today, 7:12 AM

Atai Life Sciences Launches New Salvia Divinorum Subsidiary Atai Life Sciences (NASDAQ: ATAI) announced the launch of a new subsidiary that will research Salvinorin A, the active compound in salvia divinorum, a hallucinogenic herb native to Central America.

ATAI

1 minute read

ATAI Life Sciences Q2 EPS $(0.37) Misses $0.01 Estimate

By Luke J Jacobi

Today, 7:12 AM

ATAI Life Sciences (NASDAQ:ATAI) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $0.01 by 3800 percent.

ATAI

8 minute read

Earnings Scheduled For August 16, 2021

By Benzinga Insights

Today, 7:12 AM

Companies Reporting Before The Bell • Entera Bio (NASDAQ:ENTX) is likely to report earnings for its second quarter. • Data Storage (NASDAQ:DTST) is expected to report earnings for its second quarter.

ACRX

6 minute read

The Daily Biotech Pulse: Moderna’s Vaccine Produces Durable Response Against Variants, FDA Approves Jazz’s Sleep Disorder Drug, Dermata IPO

By Shanthi Rexaline

Today, 7:12 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12)

ABVC

1 minute read

Peter Thiel Backed Atai Life Launches New Mental Health Disorders-Focused Company

By Vandana Singh

Today, 7:12 AM

Peter Thiel-backed Atai Life Sciences (NASDAQ:ATAI) has launched a new portfolio company, Revixia Life Sciences. Revixia Life’s primary mission is to develop…

ATAI

4 minute read

FDA
News

Atai Launches Revixia Life Sciences To Develop Salvinorin A For Variety Of Mental Health Conditions

By Steve Krause

Today, 7:12 AM

atai Life Sciences (NASDAQ:ATAI) ("atai"), a clinical-stage biopharmaceutical company aiming to transform the treat

ATAI

2 minute read

Atai Life Sciences To Research Potent Psychedelic Herb Salvia Divinorum Through Its New Subsidiary

By Natan Ponieman

Today, 7:12 AM

Atai Life Sciences (NASDAQ: ATAI) has announced the launch of a new subsidiary that will research Salvinorin A, the active compound in salvia divinorum, a hallucinogenic herb native to Central America.

ATAI